Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-12

Clinical Trial Update: Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effect of tenofovir on genital HSV shedding has completed with posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir (Tenofovir)

Snippet

Sponsor: University of Washington | Conditions: Herpes Simplex Type II | Phase 4 | Status: COMPLETED | Results posted: 2016-01-12